We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

81 hedge funds and large institutions have $501M invested in NeuroDerm Ltd. Ordinary Shares in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

38% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 13

21% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 38

20% more capital invested

Capital invested by funds: $418M → $501M (+$83M)

11% more funds holding

Funds holding: 73 → 81 (+8)

17% less call options, than puts

Call options by funds: $2.35M | Put options by funds: $2.83M

Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
2.02%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
46
Increased
18
Reduced
13
Closed
38
Calls
$2.35M
Puts
$2.83M
Net Calls
-$476K
Net Calls Change
-$7.87M

Top Buyers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
+$50.4M
2
SAM
Sandell Asset Management
New York
+$41.5M
3
OP
Omni Partners
United Kingdom
+$41.1M
4
JP Morgan Chase
JP Morgan Chase
New York
+$27.2M
5
OAM
Oxford Asset Management
United Kingdom
+$21.7M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$154M
2
MMH
Menora Mivtachim Holdings
Israel
-$24.2M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$23.2M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$21.2M
5
Franklin Resources
Franklin Resources
California
-$19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
51
Swiss National Bank
Switzerland
$1.1M – – –
Ameriprise
52
Ameriprise
Minnesota
$1.03M +$979K +26,614 New
AA
53
ALPS Advisors
Colorado
$1.01M +$79.6K +2,165 +9%
PP
54
Paloma Partners
Connecticut
$984K +$931K +25,300 New
CS
55
Credit Suisse
Switzerland
$967K -$575K -15,641 -39%
Barclays
56
Barclays
United Kingdom
$912K +$824K +22,400 +2,092%
I
57
INVST
Indiana
$888K +$840K +22,833 New
PAM
58
Panagora Asset Management
Massachusetts
$816K +$772K +20,986 New
CL
59
CSS LLC
Illinois
$797K +$754K +20,496 New
DAM
60
DLD Asset Management
New York
$739K +$699K +19,000 New
Geode Capital Management
61
Geode Capital Management
Massachusetts
$693K +$8.61K +234 +1%
CSS
62
Cubist Systematic Strategies
Connecticut
$650K +$614K +16,697 New
Millennium Management
63
Millennium Management
New York
$584K -$211K -5,731 -28%
HCMT
64
Highland Capital Management (Texas)
Texas
$533K +$504K +13,700 New
PPA
65
Parametric Portfolio Associates
Washington
$467K -$140K -3,817 -24%
AA
66
Ancora Advisors
Ohio
$389K +$368K +10,000 New
TCIM
67
TIAA CREF Investment Management
New York
$367K -$731K -19,883 -68%
BHCM
68
Brevan Howard Capital Management
Jersey
$363K +$343K +9,334 New
OC
69
Oppenheimer & Co
New York
$337K +$7.83K +213 +3%
Simplex Trading
70
Simplex Trading
Illinois
$308K +$292K +7,928 New
EMG
71
ETF Managers Group
New Jersey
$291K +$17.5K +475 +7%
VanEck Associates
72
VanEck Associates
New York
$192K +$8.09K +220 +5%
OTC
73
Opera Trading Capital
France
$140K +$133K +3,611 New
IA
74
IFP Advisors
Florida
$64K -$68.1K -1,850 -53%
QT
75
Quantbot Technologies
New York
$62K +$58.9K +1,600 New
1 2
3
4 5

NDRM Hedge Fund Activity: Q3 2017 in Review

81 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q3 2017, worth a combined $501M — up 20% from $418M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new NDRM positions and 38 closed out — a net gain of 8 holders — while 18 added to existing stakes and 13 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $50.4M. The largest seller was Scopia Capital Management, cutting an estimated $154M.

  • 81 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q3 2017, up from 73 in Q2 2017.
  • Funds reported $501M of NeuroDerm Ltd. Ordinary Shares stock for Q3 2017, up 20% quarter-over-quarter.
  • 46 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q3 2017 and 38 closed out, a net change of +8 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q3 2017 was AQR Arbitrage, an estimated $50.4M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q3 2017 was Scopia Capital Management, an estimated $154M sold.

Based on aggregated 13F filings for Q3 2017.